CVE-2026-66340: medium-severity vulnerability in Quanovate Tech Inc. (operating as Mira / Mira…
Mira Hormone Monitor, Mira Android App Improper restriction of excessive authentication attempts
Published · Updated
E-mail alert when it lands in KEV, gets a public PoC or its score goes up.
13Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 6.9epss 0.4%
The Mira cloud authentication endpoints do not enforce per-account rate limiting, per-IP throttling, or account lockout after repeated failed login attempts. An attacker can use brute-force methods to obtain gain access to user accounts.
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N
Affected products
Quanovate Tech Inc. (operating as Mira / Mira Care) · Mira Android AppQuanovate Tech Inc. (operating as Mira / Mira Care) · Mira FirmwareRelated CVEs — Quanovate Tech Inc. (operating as Mira / Mira…
In the same product, most dangerous first.
CVE-2026-68067CRITICALMira Hormone Monitor, Mira Android App Weak AuthenticationEPSS 0.5%CVE-2026-67568CRITICALMira Hormone Monitor, Mira Android App Use of Hard-coded CredentialsEPSS 0.4%CVE-2026-66875HIGHMira Hormone Monitor, Mira Android App Missing authentication for critical functionEPSS 0.4%CVE-2026-66832MEDIUMMira Hormone Monitor, Mira Android App Use of GET request method with sensitive query stringsEPSS 0.4%CVE-2026-66098HIGHMira Hormone Monitor, Mira Android App Missing authentication for critical functionEPSS 0.3%CVE-2026-64934MEDIUMMira Hormone Monitor, Mira Android App Reliance on untrusted inputs in a security decisionEPSS 0.3%